IPSC
Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) has 12 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 15, 2026.
The most active filer is SVP Finance & Operations Carr Douglas with 4 filings.
- Industry:Biotechnology
- CEO:Brent Pfeiffenberger
- Employees:140
- HQ:Philadelphia, PA, US
- IPO:2021-06-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$55K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$369.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| See Remarks | Sale | 2,584 | $6K | Jun 15 | SEC ↗ | |
| SVP Finance & Operations | Sale | 1,654 | $4K | Jun 15 | SEC ↗ | |
| See Remarks | Sale | 524 | $1K | Jun 9 | SEC ↗ | |
| SVP Finance & Operations | Sale | 249 | $526 | Jun 9 | SEC ↗ | |
| SVP Finance & Operations | Sale | 264 | $618 | May 6 | SEC ↗ | |
Carr DouglasFirst filing | SVP Finance & Operations | Sale | 7,043 | $18K | Mar 16 | SEC ↗ |
Russotti GregoryFirst filing | See Remarks | Sale | 10,076 | $26K | Mar 16 | SEC ↗ |
Related companies
Century Therapeutics, Inc. is in the Healthcare sector.